379 related articles for article (PubMed ID: 28434945)
1. Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties.
Cai J; Li B; Zhu Y; Fang X; Zhu M; Wang M; Liu S; Jiang X; Zheng J; Zhang X; Chen P
EBioMedicine; 2017 May; 19():18-30. PubMed ID: 28434945
[TBL] [Abstract][Full Text] [Related]
2. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
3. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
4. Identifying prognostic features by bottom-up approach and correlating to drug repositioning.
Li W; Yu J; Lian B; Sun H; Li J; Zhang M; Li L; Li Y; Liu Q; Xie L
PLoS One; 2015; 10(3):e0118672. PubMed ID: 25738841
[TBL] [Abstract][Full Text] [Related]
5. CDK1-PLK1/SGOL2/ANLN pathway mediating abnormal cell division in cell cycle may be a critical process in hepatocellular carcinoma.
Li L; Huang K; Zhao H; Chen B; Ye Q; Yue J
Cell Cycle; 2020 May; 19(10):1236-1252. PubMed ID: 32275843
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of EPHX2 as a prognostic biomarker in hepatocellular carcinoma.
Zhan K; Bai Y; Liao S; Chen H; Kuang L; Luo Q; Lv L; Qiu L; Mei Z
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278494
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics Analysis Identifies Protein Tyrosine Kinase 7 (PTK7) as a Potential Prognostic and Therapeutic Biomarker in Stages I to IV Hepatocellular Carcinoma.
Zou RC; Liang Y; Li LL; Tang JZ; Yang YP; Geng YC; He J; Luo LY; Li WX; Sun ZW; Yuan HL
Med Sci Monit; 2019 Nov; 25():8618-8627. PubMed ID: 31730575
[TBL] [Abstract][Full Text] [Related]
8. Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma.
Grinchuk OV; Yenamandra SP; Iyer R; Singh M; Lee HK; Lim KH; Chow PK; Kuznetsov VA
Mol Oncol; 2018 Jan; 12(1):89-113. PubMed ID: 29117471
[TBL] [Abstract][Full Text] [Related]
9. Identification of genes in hepatocellular carcinoma induced by non-alcoholic fatty liver disease.
Cai C; Song X; Yu C
Cancer Biomark; 2020; 29(1):69-78. PubMed ID: 32623384
[TBL] [Abstract][Full Text] [Related]
10. Analysis of potential key genes in very early hepatocellular carcinoma.
Wu M; Liu Z; Li X; Zhang A; Lin D; Li N
World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
[TBL] [Abstract][Full Text] [Related]
12. A six-gene-based prognostic signature for hepatocellular carcinoma overall survival prediction.
Wang Z; Teng D; Li Y; Hu Z; Liu L; Zheng H
Life Sci; 2018 Jun; 203():83-91. PubMed ID: 29678742
[TBL] [Abstract][Full Text] [Related]
13. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
14. A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma.
Liu WT; Wang Y; Zhang J; Ye F; Huang XH; Li B; He QY
Cancer Lett; 2018 Jul; 425():43-53. PubMed ID: 29608985
[TBL] [Abstract][Full Text] [Related]
15. Unique microRNA alterations in hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N mice.
Yamashita H; Surapureddi S; Kovi RC; Bhusari S; Ton TV; Li JL; Shockley KR; Peddada SD; Gerrish KE; Rider CV; Hoenerhoff MJ; Sills RC; Pandiri AR
Arch Toxicol; 2020 Jul; 94(7):2523-2541. PubMed ID: 32306082
[TBL] [Abstract][Full Text] [Related]
16. Expression of connective tissue growth factor in the livers of non-viral hepatocellular carcinoma patients with metabolic risk factors.
Akahoshi K; Tanaka S; Mogushi K; Shimada S; Matsumura S; Akiyama Y; Aihara A; Mitsunori Y; Ban D; Ochiai T; Kudo A; Arii S; Tanabe M
J Gastroenterol; 2016 Sep; 51(9):910-22. PubMed ID: 26739296
[TBL] [Abstract][Full Text] [Related]
17. A signature of 33 immune-related gene pairs predicts clinical outcome in hepatocellular carcinoma.
Sun XY; Yu SZ; Zhang HP; Li J; Guo WZ; Zhang SJ
Cancer Med; 2020 Apr; 9(8):2868-2878. PubMed ID: 32068352
[TBL] [Abstract][Full Text] [Related]
18. Systematic profiling of a novel prognostic alternative splicing signature in hepatocellular carcinoma.
Zhang D; Duan Y; Wang Z; Lin J
Oncol Rep; 2019 Dec; 42(6):2450-2472. PubMed ID: 31578577
[TBL] [Abstract][Full Text] [Related]
19. Integrative analysis reveals the prognostic value and functions of splicing factors implicated in hepatocellular carcinoma.
Wang Y; Yang F; Shang J; He H; Yang Q
Sci Rep; 2021 Jul; 11(1):15175. PubMed ID: 34312475
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of PRRX1 Confers Cancer Stem Cell-Like Properties and Predicts Poor Prognosis in Hepatocellular Carcinoma.
Hirata H; Sugimachi K; Takahashi Y; Ueda M; Sakimura S; Uchi R; Kurashige J; Takano Y; Nanbara S; Komatsu H; Saito T; Shinden Y; Iguchi T; Eguchi H; Atsumi K; Sakamoto K; Doi T; Hirakawa M; Honda H; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1402-9. PubMed ID: 25404478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]